The Tyrosine Kinase-Driven Networks of Novel Long Non-coding RNAs and Their Molecular Targets in Myeloproliferative Neoplasms by Nonthaphat Kent Wong, Shumeng Luo, Eudora Y. D. Chow, Fei Meng, Adenike Adesanya, Jiahong Sun, Jiahong Sun, Herman M. H. Ma, Herman M. H. Ma, Wenfei Jin, Wan-Chun Li, Shea Ping Yip, Chien-Ling Huang

Subjects: Get full text

Pharmacoeconomic modeling of target therapy of chronic myeloid leukemia in remission by V. A. Shuvaev, K. M. Abdulkadyrov, I. S. Martynkevich, M. S. Fominykh

Subjects: “…chronic myelogenous leukemia…”
Get full text

Pathobiology and Therapeutic Relevance of GSK-3 in Chronic Hematological Malignancies by Alberto M. Martelli, Francesca Paganelli, Camilla Evangelisti, Francesca Chiarini, James A. McCubrey

Subjects: Get full text

CML derived exosomes promote tumor favorable functional performance in T cells by Nazli Jafarzadeh, Mohammad Ali Gholampour, Mohammad-Reza Alivand, Saeideh Kavousi, Laleh Arzi, Fariba Rad, Majid Sadeghizadeh, Majid Pornour

Subjects: Get full text

Ponatinib and other CML Tyrosine Kinase Inhibitors in Thrombosis by Peng Zeng, Alvin Schmaier

Subjects: Get full text

Successful Preservation of Native BCR::ABL1 in Chronic Myeloid Leukemia Primary Leukocytes Reveals a Reduced Kinase Activity by Christian Boni, Massimiliano Bonifacio, Marzia Vezzalini, Luigi Scaffidi, Luisa Tomasello, Laurie L. Parker, Diego Boscarino, Dino Paladin, Mauro Krampera, Claudio Sorio

Subjects: “…chronic myelogenous leukemia…”
Get full text

HDAC I/IIb selective inhibitor Purinostat Mesylate combined with GLS1 inhibition effectively eliminates CML stem cells by Qiang Qiu, Linyu yang, Yunyu Feng, Zejiang Zhu, Ning Li, Li Zheng, Yuanyuan Sun, Cong Pan, Huandi Qiu, Xue Cui, Wei He, Fang Wang, Yuyao Yi, Minghai Tang, Zhuang Yang, Yunfan Yang, Zhihui Li, Lijuan Chen, Yiguo Hu

Subjects: “…Chronic myelogenous leukemia…”
Get full text

Effect of Tyrosin Kinase Inhibitors on NK Cell and ILC3 Development and Function by Laura Damele, Laura Damele, Elisa Montaldo, Lorenzo Moretta, Chiara Vitale, Chiara Vitale, Maria Cristina Mingari, Maria Cristina Mingari, Maria Cristina Mingari

Subjects: Get full text

Identification of homogeneously staining regions in leukemia patients by Mohammad Heydarian Moghadam, Abolfazl Movafagh, MirDavood Omrani, Kiandokht Ghanati, Mehrdad Hashemi, Farhikhteh Poursafavi, Hossein Darvish, Davood Zare Abdolahi, Milad Gholami, Mohammad Reza Heidari Rostamy, Shamsi Safari, Leyla HaghNejad, Reyhaneh Darehgazani, Niloofar Safavi Naeini, Mehdi Ghandehari Motlagh, Davar Amani

Subjects: Get full text

Identification of TCR Vβ11-2-Dβ1-Jβ1-1 T cell clone specific for WT1 peptides using high-throughput TCRβ gene sequencing by Yikai Zhang, Ling Xu, Shaohua Chen, Xianfeng Zha, Wei Wei, Yangqiu Li

Subjects: “…Chronic myelogenous leukemia…”
Get full text

Debating Frontline Therapy in Chronic Myeloid Leukemia by Xia Bi, Sabarina Ramanathan, Gina Keiffer

Subjects: “…CML - chronic myelogenous leukemia…”
Get full text

Existence of periodic solutions in the modified Wheldon model of CML by Pablo Amster, Rocio Balderrama, Lev Idels

Subjects: Get full text

Decay of non-oscillatory solutions for a system of neutral differential equations by Helena Samajova, Eva Spanikova, Julio G. Dix

Subjects: Get full text

Mechanistic Insights Into Co-Administration of Allosteric and Orthosteric Drugs to Overcome Drug-Resistance in T315I BCR-ABL1 by Hao Zhang, Hao Zhang, Mingsheng Zhu, Mingzi Li, Duan Ni, Yuanhao Wang, Liping Deng, Kui Du, Shaoyong Lu, Hui Shi, Chen Cai

Subjects: “…chronic myelogenous leukemia (CML)…”
Get full text

Small molecule protein kinase inhibitors approved by regulatory agencies outside of the United States by Robert Roskoski Jr.

Subjects: Get full text

Somatic Mutations in Oncogenes Are in Chronic Myeloid Leukemia Acquired De Novo via Deregulated Base-Excision Repair and Alternative Non-Homologous End Joining by Nikola Curik, Nikola Curik, Vaclava Polivkova, Pavel Burda, Pavel Burda, Jitka Koblihova, Adam Laznicka, Adam Laznicka, Tomas Kalina, Veronika Kanderova, Jana Brezinova, Sarka Ransdorfova, Dominika Karasova, Katerina Rejlova, Marina Bakardjieva, Daniela Kuzilkova, David Kundrat, Jana Linhartova, Hana Klamova, Cyril Salek, Pavel Klener, Pavel Klener, Ondrej Hrusak, Katerina Machova Polakova, Katerina Machova Polakova

Subjects: “…chronic myelogenous leukemia (CML)…”
Get full text

Dasatinib: ten years of clinical practice worldwide by K. M. Abdulkadyrov, V. A. Shuvaev, I. S. Martynkevich

Subjects: Get full text

Tratamento da recidiva da leucemia mielóide crônica após transplante de medula óssea alogênico utilizando mesilato de imatinibe: relato de três casos Treatment of chronic myelogenous leukemia relapse after allogeneic bone marrow transplantation with imatinib mesylate: report of three cases by Ronald Pallotta, Denize F. Lima, Flávia Cal, Maiana Almeida, Mônica Conchon

“…<br>Imatinib mesylate (MI), a selective tyrosine kinase inhibitor involved in the pathogenesis of chronic myelogenous leukemia (CML), has become the first-line treatment for this disease. …”
Get full text

Exploration of treatment‐free remission in CML, based on molecular monitoring by Zhao Zhang, Xianghui Zhou, Xin Zhou, Zhipeng Cheng, Yu Hu

Subjects: Get full text

Impact of chromosomal rearrangement upon DNA methylation patterns in leukemia by Byun Hyang-Min, Eshaghian Shahrooz, Douer Dan, Trent Jonathen, Garcia-Manero Guillermo, Bhatia Ravi, Siegmund Kim, Yang Allen S.

Subjects: Get full text